Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03490877 · ClinicalTrials.gov registry record
Scratch and Sleep Quantification in Atopic Dermatitis
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 45
- Enrollment target
NCT03490877 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 45 participants.
The verdict
NCT03490877 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
Atopic dermatitis (AD) is a chronic type of eczema affecting approximately 10% of adults and 12% of children in the US. The intense itching (pruritus) associated with AD can be significantly disruptive to sleep and quality of life for both the patients and their caregivers. AD is challenging to describe and measure. The purpose of this study is to see if we can reliably measure how much people with AD scratch and how scratching interferes with sleep and quality of life by using digital sensors, sleep studies and patient-reported information.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2018-07-13 |
| Est. Completion | 2019-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03490877
The ClinicalTrials.gov registry entry for NCT03490877 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03490877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03490877 about?
NCT03490877 is a clinical study titled "Scratch and Sleep Quantification in Atopic Dermatitis". Atopic dermatitis (AD) is a chronic type of eczema affecting approximately 10% of adults and 12% of children in the US. The intense itching (pruritus) associated with AD can be significantly disruptive to sleep and quality of life for both the patients and their caregivers. AD is challenging to desc...
What is the current status of trial NCT03490877?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2018-07-13. Estimated completion is 2019-09-30.
Who is sponsoring clinical trial NCT03490877?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.